Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
Logo Image
|Articles|August 22, 2022

Research and Markets Releases 2022 Digital Biomarkers Drug Development Market Report

The "Growth Opportunities for Digital Biomarkers in Drug Development" report has been added to ResearchAndMarkets.com's offering. The study focuses on 3 major therapy areas, neurology, oncology, and cardiology, which digital biomarkers impact.

Key topics covered:

  1. Strategic Imperatives
  2. Growth Opportunity Analysis
  1. Growth Opportunity Analysis - Neurology
  2. Growth Opportunity Analysis - Oncology
  3. Regulatory Landscape
  4. Industry Assessment and Analysis
  5. Patent Landscape
  6. Growth Opportunity Universe

Read more about the report here.

Related to this article

View more
Where AI Leads in Trial Design—and Where Humans Still Need To
Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.
Read more